https://elutinc.com/cima/2022-08-17T06:16:36-06:00https://elutinc.com/serbousek/2022-08-17T06:16:31-06:00https://elutinc.com/allowance/2022-08-17T06:16:53-06:00https://elutinc.com/notification-issuance-key-patent/2022-08-17T06:16:08-06:00https://elutinc.com/innovation-leader-emerging-medtech-summit/2022-08-17T06:16:14-06:00https://elutinc.com/hss-rothman-jefferson-clinical-trial/2022-08-17T06:16:26-06:00https://elutinc.com/elute-inc-announces-first-clinical-trial-authorization-by-fda-for-use-of-its-antibiotic-eluting-bone-void-filler-product/2022-08-17T06:16:20-06:00https://elutinc.com/2025-12-18T18:43:57-07:00https://elutinc.com/new-class-bvf/2022-08-16T21:45:46-06:00https://elutinc.com/approach/2022-08-16T21:50:35-06:00https://elutinc.com/approach/science/2025-09-10T19:00:12-06:00https://elutinc.com/ep-granules-tobramycin/2025-03-18T19:45:50-06:00https://elutinc.com/impact/2022-08-16T21:54:39-06:00https://elutinc.com/clinical-study/2022-08-16T21:48:16-06:00https://elutinc.com/about/2026-03-05T20:20:40-07:00https://elutinc.com/privacy/2022-08-16T21:51:32-06:00https://elutinc.com/contact/2026-02-23T20:41:44-07:00https://elutinc.com/temp/2023-12-29T12:10:00-07:00https://elutinc.com/bonvie/2025-12-28T20:26:07-07:00https://elutinc.com/bonvie-temporary/2025-12-19T21:31:39-07:00